TytoCare
Summary active Updated Jul 19, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Investors
Founders
About
TytoCare is a New York- and Netanya, Israel-based digital-health company that develops FDA-cleared handheld devices and AI-powered software algorithms for remote physical examinations, capturing clinical-grade heart, lung, ear, skin, throat, and abdominal data 123. The platform is used by health systems, payers, and employer health programs to deliver primary care, cardiopulmonary care, and oncology-related monitoring outside of in-person visits 23. On 2026-07-15 TytoCare announced a growth round of more than $25 million led by Insight Partners, and appointed Adam Pellegrini as chief executive officer and Greg Orr as chief operating officer 123. The company said the funds will deepen integrations with health systems and payers, with a particular focus on congestive heart failure, COPD, post-surgical recovery, and oncology treatment monitoring 23.
Disclaimer: This is a lean profile built from initial round coverage and may be expanded as more information becomes available.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-07-15 | Growth | $25M+ | Insight Partners | HOOP, OliveTree, OrbiMed, Qumra Capital, Qualcomm Ventures, West Fountain Global Fund, Echo Health Ventures, MTIP Health, Memorial Care 123 |
What Investors Say
“Health systems have wanted to extend real clinical care into the home for years. The barrier has long been diagnostic fidelity.”
— Jeff Horing, Co-Founder & Managing Director, Insight Partners 2
What Founders Say
“TytoCare has built the foundational infrastructure for the next generation of intelligent remote care.”
— Adam Pellegrini, Chief Executive Officer, TytoCare 2
Sources
-
“TytoCare Raises $25M+ in Funding,” FinSMEs, July 16, 2026. Accessed July 2026. https://www.finsmes.com/2026/07/tytocare-raises-25m-in-funding.html↩↩↩
-
“TytoCare Names Adam Pellegrini as CEO and Closes $25M+ Growth Round to Scale AI-First Clinical Enablement Platform,” PR Newswire, July 15, 2026. Accessed July 2026. https://www.prnewswire.com/news-releases/tytocare-names-adam-pellegrini-as-ceo-and-closes-25m-growth-round-to-scale-ai-first-clinical-enablement-platform-302825623.html↩↩↩↩↩↩↩
-
“TytoCare Secures $25M and Appoints Adam Pellegrini as CEO,” HIT Consultant, July 16, 2026. Accessed July 2026. https://hitconsultant.net/2026/07/16/tytocare-closes-25-million-growth-round-ceo-pellegrini/↩↩↩↩↩